Bolt Biotherapeutics Inc. (BOLT) NASDAQ
$0.89 0.04 (4.34%)
Market Cap: $33.79M
As of 12/01/23 04:00 PM EST. Market closed.
Bolt Biotherapeutics Inc. (BOLT)
NASDAQ
$0.89
0.04 (4.34%)
Market Cap: $33.79M
As of 12/01/23 04:00 PM EST. Market closed.
Add to Portfolio
bolt biotherapeutics is a start-up with compelling technology from dr. engleman’s lab at stanford university, which demonstrated complete cures in numerous cancer models. the company is backed by strong life sciences investors and is early in its growth curve, seeking bright, highly motivated individuals that will be the company’s future leaders to help it further develop and bring to ... read more
bolt biotherapeutics is a start-up with compelling technology from dr. engleman’s lab at stanford university, which demonstrated complete cures in numerous cancer models. the company is backed by strong life sciences investors and is early in its growth curve, seeking bright, highly motivated individuals that will be the company’s future leaders to help it further develop and bring to patients novel and curative biotherapies. read less
COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
640 Galveston Drive, California, Redwood City, 94063.
PRICE CHART FOR BOLT BIOTHERAPEUTICS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$0.89
Previous Close
$0.85
Days Range
$0.84 - $0.92
52 week range
$0.84 - $2.03
Volume
70,710
Avg. Volume (30 days)
75,358
Market Cap
$33.79M
Dividend Yield
-
P/E
(0.47)
Shares Outstanding
37,965,870
Open
$0.89
Previous Close
$0.85
Days Range
$0.84 - $0.92
52 week range
$0.84 - $2.03
Volume
70,710
Avg. Volume (30 days)
75,358
Market Cap
$33.79M
Dividend Yield
-
P/E
(0.47)
Shares Outstanding
37,965,870
FINANCIAL STATEMENTS FOR BOLT BIOTHERAPEUTICS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR BOLT BIOTHERAPEUTICS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| ENGLEMAN EDGAR | Director | Nov 30, 2023 | Sale | $0.86 | 14,934 | 12,815 | 251,522 | Dec 01, 2023, 12:31 PM |
| ENGLEMAN EDGAR | Director | Nov 29, 2023 | Sale | $0.91 | 3,131 | 2,837 | 266,456 | Dec 01, 2023, 12:31 PM |
| ENGLEMAN EDGAR | Director | Nov 30, 2023 | Sale | $0.86 | 108,145 | 92,799 | 1,821,483 | Dec 01, 2023, 12:31 PM |
| ENGLEMAN EDGAR | Director | Nov 29, 2023 | Sale | $0.91 | 22,674 | 20,543 | 1,929,628 | Dec 01, 2023, 12:31 PM |
| ENGLEMAN EDGAR | Director | Nov 21, 2023 | Sale | $0.90 | 236 | 213 | 269,587 | Nov 22, 2023, 07:45 PM |
| ENGLEMAN EDGAR | Director | Nov 21, 2023 | Sale | $0.90 | 1,707 | 1,539 | 1,952,302 | Nov 22, 2023, 07:45 PM |
| Vivo Capital VIII, LLC | 10% Owner | Nov 21, 2023 | Sale | $0.90 | 1,457 | 1,311 | 111,662 | Nov 22, 2023, 06:51 PM |
| Vivo Capital VIII, LLC | 10% Owner | Nov 21, 2023 | Sale | $0.90 | 236 | 212 | 269,587 | Nov 22, 2023, 06:51 PM |
| Vivo Capital VIII, LLC | 10% Owner | Nov 21, 2023 | Sale | $0.90 | 1,707 | 1,536 | 1,952,302 | Nov 22, 2023, 06:51 PM |
| ENGLEMAN EDGAR | Director | Nov 17, 2023 | Sale | $0.93 | 8,211 | 7,636 | 1,981,474 | Nov 20, 2023, 09:31 PM |
| ENGLEMAN EDGAR | Director | Nov 16, 2023 | Sale | $0.96 | 7,531 | 7,230 | 1,989,685 | Nov 20, 2023, 09:31 PM |
| ENGLEMAN EDGAR | Director | Nov 20, 2023 | Sale | $0.92 | 3,792 | 3,489 | 269,823 | Nov 20, 2023, 09:31 PM |
| ENGLEMAN EDGAR | Director | Nov 17, 2023 | Sale | $0.93 | 1,134 | 1,055 | 273,615 | Nov 20, 2023, 09:31 PM |
| ENGLEMAN EDGAR | Director | Nov 16, 2023 | Sale | $0.96 | 1,040 | 998 | 274,749 | Nov 20, 2023, 09:31 PM |
| ENGLEMAN EDGAR | Director | Nov 20, 2023 | Sale | $0.92 | 27,465 | 25,268 | 1,954,009 | Nov 20, 2023, 09:31 PM |
| Vivo Capital VIII, LLC | 10% Owner | Nov 17, 2023 | Sale | $0.93 | 1,134 | 1,055 | 273,615 | Nov 20, 2023, 09:09 PM |
| Vivo Capital VIII, LLC | 10% Owner | Nov 17, 2023 | Sale | $0.93 | 8,211 | 7,636 | 1,981,474 | Nov 20, 2023, 09:09 PM |
| Vivo Capital VIII, LLC | 10% Owner | Nov 16, 2023 | Sale | $0.96 | 6,429 | 6,172 | 143,571 | Nov 20, 2023, 09:09 PM |
| Vivo Capital VIII, LLC | 10% Owner | Nov 20, 2023 | Sale | $0.92 | 23,443 | 21,568 | 113,119 | Nov 20, 2023, 09:09 PM |
| Vivo Capital VIII, LLC | 10% Owner | Nov 16, 2023 | Sale | $0.96 | 1,040 | 998 | 274,749 | Nov 20, 2023, 09:09 PM |
| Vivo Capital VIII, LLC | 10% Owner | Nov 20, 2023 | Sale | $0.92 | 3,792 | 3,489 | 269,823 | Nov 20, 2023, 09:09 PM |
| Vivo Capital VIII, LLC | 10% Owner | Nov 16, 2023 | Sale | $0.96 | 7,531 | 7,230 | 1,989,685 | Nov 20, 2023, 09:09 PM |
| Vivo Capital VIII, LLC | 10% Owner | Nov 20, 2023 | Sale | $0.92 | 27,465 | 25,268 | 1,954,009 | Nov 20, 2023, 09:09 PM |
| Vivo Capital VIII, LLC | 10% Owner | Nov 17, 2023 | Sale | $0.93 | 7,009 | 6,518 | 136,562 | Nov 20, 2023, 09:09 PM |
| Novo Holdings A/S | 10% Owner | Jul 13, 2022 | Sale | $2.00 | 800,000 | 1,600,000 | 3,703,991 | Jul 15, 2022, 04:16 PM |
| Perez Edith A. | Chief Medical Officer | Dec 22, 2021 | Option Exercise | $2.80 | 35,714 | 99,999 | 37,042 | Feb 01, 2022, 07:18 PM |
| Perez Edith A. | Chief Medical Officer | Dec 06, 2021 | Buy | $4.64 | 411 | 1,907 | 1,328 | Feb 01, 2022, 07:18 PM |
| Perez Edith A. | Chief Medical Officer | Jun 04, 2021 | Buy | $16.65 | 917 | 15,268 | 917 | Feb 01, 2022, 07:18 PM |
| Quinn William P. | Chief Financial Officer | Dec 08, 2021 | Buy | $4.72 | 5,000 | 23,575 | 20,154 | Dec 09, 2021, 04:05 PM |
| Quinn William P. | Chief Financial Officer | Dec 06, 2021 | Buy | $4.64 | 35 | 162 | 15,154 | Dec 09, 2021, 04:05 PM |
| Quinn William P. | Chief Financial Officer | Jun 04, 2021 | Buy | $16.65 | 1,221 | 20,330 | 15,119 | Dec 09, 2021, 04:05 PM |
| Novo Holdings A/S | 10% Owner | Feb 09, 2021 | Buy | $20.00 | 400,000 | 8,000,000 | 4,503,991 | Feb 11, 2021, 04:39 PM |
| Sofinnova Venture Partners X, L.P. | 10% Owner | Feb 09, 2021 | Buy | $20.00 | 450,000 | 9,000,000 | 2,754,437 | Feb 09, 2021, 06:04 PM |
| Vivo Capital VIII, LLC | 10% Owner | Feb 09, 2021 | Buy | $20.00 | 150,000 | 3,000,000 | 150,000 | Feb 09, 2021, 03:37 PM |
| Vivo Capital VIII, LLC | 10% Owner | Feb 09, 2021 | Buy | $20.00 | 24,267 | 485,340 | 275,789 | Feb 09, 2021, 03:37 PM |
| Vivo Capital VIII, LLC | 10% Owner | Feb 09, 2021 | Buy | $20.00 | 175,733 | 3,514,660 | 1,997,216 | Feb 09, 2021, 03:37 PM |
| Vivo Capital VIII, LLC | 10% Owner | Feb 09, 2021 | Sale | $20.00 | 144 | 2,880 | 1,821,483 | Feb 09, 2021, 03:37 PM |
| Vivo Capital VIII, LLC | 10% Owner | Feb 09, 2021 | Sale | $20.00 | 62 | 1,240 | 1,448,286 | Feb 09, 2021, 03:37 PM |
| Vivo Capital VIII, LLC | 10% Owner | Feb 09, 2021 | Sale | $20.00 | 20 | 400 | 251,522 | Feb 09, 2021, 03:37 PM |
| Vivo Capital VIII, LLC | 10% Owner | Feb 09, 2021 | Option Exercise | $0.07 | 40,953 | 2,867 | 1,821,627 | Feb 09, 2021, 03:37 PM |
| Vivo Capital VIII, LLC | 10% Owner | Feb 09, 2021 | Option Exercise | $0.07 | 17,711 | 1,240 | 1,448,348 | Feb 09, 2021, 03:37 PM |
| Vivo Capital VIII, LLC | 10% Owner | Feb 09, 2021 | Option Exercise | $0.07 | 5,655 | 396 | 251,542 | Feb 09, 2021, 03:37 PM |
| LAPORTE KATHLEEN | Director | Feb 09, 2021 | Buy | $20.00 | 1,200 | 24,000 | 1,200 | Feb 09, 2021, 03:35 PM |
| SHAH MAHENDRA | Director | Feb 09, 2021 | Sale | $20.00 | 62 | 1,240 | 1,448,286 | Feb 09, 2021, 03:33 PM |
| SHAH MAHENDRA | Director | Feb 09, 2021 | Option Exercise | $0.07 | 17,711 | 1,240 | 1,448,348 | Feb 09, 2021, 03:33 PM |
| HEALY JAMES | Director | Feb 09, 2021 | Buy | $20.00 | 450,000 | 9,000,000 | 2,754,437 | Feb 09, 2021, 03:29 PM |
| Khanna Ashish Siri Ram | Director | Feb 09, 2021 | Buy | $20.00 | 1,200 | 24,000 | 1,200 | Feb 09, 2021, 03:27 PM |
| Khanna Ashish Siri Ram | Director | Feb 09, 2021 | Buy | $20.00 | 1,000 | 20,000 | 1,000 | Feb 09, 2021, 03:27 PM |
| ENGLEMAN EDGAR | Director | Feb 09, 2021 | Buy | $20.00 | 175,733 | 3,514,660 | 1,997,216 | Feb 09, 2021, 03:25 PM |
| ENGLEMAN EDGAR | Director | Feb 09, 2021 | Buy | $20.00 | 24,267 | 485,340 | 275,789 | Feb 09, 2021, 03:25 PM |
| ENGLEMAN EDGAR | Director | Feb 09, 2021 | Sale | $20.00 | 144 | 2,880 | 1,821,483 | Feb 09, 2021, 03:25 PM |
| ENGLEMAN EDGAR | Director | Feb 09, 2021 | Sale | $20.00 | 20 | 400 | 251,522 | Feb 09, 2021, 03:25 PM |
| ENGLEMAN EDGAR | Director | Feb 09, 2021 | Option Exercise | $0.07 | 40,953 | 2,867 | 1,821,627 | Feb 09, 2021, 03:25 PM |
| ENGLEMAN EDGAR | Director | Feb 09, 2021 | Option Exercise | $0.07 | 5,655 | 396 | 251,542 | Feb 09, 2021, 03:25 PM |
| Quinn William P. | Chief Financial Officer | Feb 09, 2021 | Buy | $20.00 | 1,200 | 24,000 | 13,898 | Feb 09, 2021, 03:23 PM |
| Schatzman Randall C | Chief Executive Officer | Feb 09, 2021 | Buy | $20.00 | 1,500 | 30,000 | 1,500 | Feb 09, 2021, 03:20 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Load More Insider Transactions
FUNDS WITH A POSITION IN BOLT BIOTHERAPEUTICS INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| VIVO CAPITAL, LLC | 3,871,291 | 0.44% | No change | Other |
| ORBIMED ADVISORS LLC | 1,541,000 | 0.03% | No change | Other |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 500,000 | 0.00118% | No change | Other |
| RENAISSANCE TECHNOLOGIES LLC | 314,189 | 0.00056% | -35.08% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 360,739 | 0.00004% | 2.42% | Other |
| BLACKROCK INC. | 258,023 | 0.00001% | -10.37% | Other |
CHANGE IN SHARES OUTSTANDING FOR BOLT BIOTHERAPEUTICS INC
STOCK BUYBACKS FOR BOLT BIOTHERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 09/30/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
06/30/2023
0.31%
1Q
03/31/2023
0.49%
2Q
12/31/2022
0.84%
3Q
09/30/2022
1.11%
4Q
06/30/2022
1.54%
5Q
03/31/2022
1.99%
6Q
12/31/2021
1.49%
7Q
09/30/2021
1.78%
8Q
06/30/2021
3.48%
9Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR BOLT BIOTHERAPEUTICS INC
LOADING...